暂时撤稿:对「中心性肥胖、混杂用药与肺癌风险『肥胖悖论』再解读」读者来信的回应
TEMPORARY REMOVAL: A Response to the Letter to the Editor: "Central Adiposity, Confounding Medications, and the Reinterpretation of the "Obesity Paradox" in Lung Cancer Risk".
PubMed 文献 · J Thorac Oncol · 2026-09-25
该文为J Thorac Oncol刊发的暂时撤稿声明,原文是对一封关于中心性肥胖、混杂用药与肺癌风险中「肥胖悖论」再解读的读者来信的回应。出版商表示文章暂时撤除,替换版本将尽快发布并说明撤稿原因,或恢复原文。声明未提供任何研究数据、方法或结论。
要点
- 本文为暂时撤稿声明,无可引用的研究数据或结论
- 原文主题涉及中心性肥胖、混杂用药与肺癌「肥胖悖论」
- 引用前应核实该文是否已被替换或恢复
核心结论
- 该文已被出版商暂时撤除,替换版本将说明撤稿原因或恢复原文。
临床怎么用
- 临床引用该文前需核实其撤稿状态及替换版本内容。
局限性
- 声明未说明撤稿具体原因,亦未提供原文数据与方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the article will be specified, or the article will be reinstated. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies-and-standards/article-withdrawal.
来源:J Thorac Oncol,查看原文。版权归原作者所有。
引用
- Barbi J, Patnaik SK, Yendamuri S, et al. TEMPORARY REMOVAL: A Response to the Letter to the Editor: "Central Adiposity, Confounding Medications, and the Reinterpretation of the "Obesity Paradox" in Lung Cancer Risk". J Thorac Oncol. 2026. PMID: 42788923. doi:10.1016/j.jtho.2026.104171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。